Sophie Sabherwal

Dublin, L, Ireland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Progressive multifocal leukoencephalopathy as the first presentation of an underlying lymphoproliferative disorder.

Progressive multifocal leukoencephalopathy as the first presentation of an underlying lymphoproliferative disorder.

Journal: Clinical neuropathology
Published: June 03, 2026

Increased Prevalence of Nitrous Oxide-Induced Subacute Combined Degeneration of the Spinal Cord: Clinical and Imaging Findings.

Increased Prevalence of Nitrous Oxide-Induced Subacute Combined Degeneration of the Spinal Cord: Clinical and Imaging Findings.

Journal: AJNR. American journal of neuroradiology
Published: June 03, 2025

Protocol for a systematic review of the validity of animal models of polydipsia with a basis in schizophrenia aetiology.

Protocol for a systematic review of the validity of animal models of polydipsia with a basis in schizophrenia aetiology.

Journal: BMJ open science
Published: January 06, 2022

Intelligence quotient decline following frequent or dependent cannabis use in youth: a systematic review and meta-analysis of longitudinal studies.

Intelligence quotient decline following frequent or dependent cannabis use in youth: a systematic review and meta-analysis of longitudinal studies.

Journal: Psychological medicine
Published: January 27, 2021

Omega-3 fatty acid in ultra-high-risk psychosis: A systematic review based on functional outcome.

Omega-3 fatty acid in ultra-high-risk psychosis: A systematic review based on functional outcome.

Journal: Early intervention in psychiatry
Published: March 17, 2020

Peripheral complement proteins in schizophrenia: A systematic review and meta-analysis of serological studies.

Peripheral complement proteins in schizophrenia: A systematic review and meta-analysis of serological studies.

Journal: Schizophrenia research
Published: January 06, 2020

ApoE elevation is associated with the persistence of psychotic experiences from age 12 to age 18: Evidence from the ALSPAC birth cohort.

ApoE elevation is associated with the persistence of psychotic experiences from age 12 to age 18: Evidence from the ALSPAC birth cohort.

Journal: Schizophrenia research
Published: September 27, 2018

Integrated Lipidomics and Proteomics Point to Early Blood-Based Changes in Childhood Preceding Later Development of Psychotic Experiences: Evidence From the Avon Longitudinal Study of Parents and Children.

Integrated Lipidomics and Proteomics Point to Early Blood-Based Changes in Childhood Preceding Later Development of Psychotic Experiences: Evidence From the Avon Longitudinal Study of Parents and Children.

Journal: Biological psychiatry
Published: August 21, 2018

Complement pathway changes at age 12 are associated with psychotic experiences at age 18 in a longitudinal population-based study: evidence for a role of stress.

Complement pathway changes at age 12 are associated with psychotic experiences at age 18 in a longitudinal population-based study: evidence for a role of stress.

Journal: Molecular psychiatry
Published: March 27, 2018

Blood-Based Protein Changes in Childhood Are Associated With Increased Risk for Later Psychotic Disorder: Evidence From a Nested Case-Control Study of the ALSPAC Longitudinal Birth Cohort.

Blood-Based Protein Changes in Childhood Are Associated With Increased Risk for Later Psychotic Disorder: Evidence From a Nested Case-Control Study of the ALSPAC Longitudinal Birth Cohort.

Journal: Schizophrenia bulletin
Published: October 17, 2017

Blood biomarker discovery in drug-free schizophrenia: the contributionof proteomics and multiplex immunoassays.

Blood biomarker discovery in drug-free schizophrenia: the contributionof proteomics and multiplex immunoassays.

Journal: Expert review of proteomics
Published: October 25, 2016
Showing 1-11 of 11

Last Updated: 09/26/2026